Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/02/2012US8277834 Method for producing protein adsorption-preventing ocular lens material
10/02/2012US8277825 Insect attractants and their use in methods of insect control
10/02/2012US8277824 Solubilization of cyclohexane-based carboxamide derivatives for use as sensates in consumer products
10/02/2012US8277818 Herpes virus strains for gene therapy
10/02/2012US8277807 Pharmaceutical combinations
10/02/2012US8277802 Diagnosis and prevention of cancer cell invasion
10/02/2012US8277801 Delivery system for functional compounds
10/02/2012US8277791 Cosmetic compositions having improved transfer resistance
10/02/2012US8277782 Antiinflammatory agent, metalloproteinase inhibitor, anti-oxidant and modifier of cell redox status, vitamins, inhibitor of activation of nuclear factor kappa beta
10/02/2012US8277775 Boron dipyrromethene difluoro (BODIPY) conjugates
10/02/2012US8277688 Aluminum alloy coated pigments and corrosion-resistant coatings
10/02/2012CA2709774C Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
10/02/2012CA2690953C Benzimidazole derivatives
10/02/2012CA2685597C Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use
10/02/2012CA2679925C Method for producing high-purity prasugrel hydrochloride
10/02/2012CA2675651C Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk] [1] -benzazepin-2 [1h] -one and zilpaterol
10/02/2012CA2674424C Hydromorphinone and hydrocodeinone compositions and methods for their synthesis
10/02/2012CA2672427C Colon cleansing compositions
10/02/2012CA2669457C Calcium-containing structures and methods of making and using the same
10/02/2012CA2666489C Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
10/02/2012CA2656057C Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
10/02/2012CA2641138C Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
10/02/2012CA2576926C Use of midostaurin for treating gastrointestinal stromal tumors
10/02/2012CA2575720C Pyrimidine derivatives
10/02/2012CA2572161C Novel arylamidine derivative, salt thereof, and antifungal containing these
10/02/2012CA2567766C Durable biocides and disinfectants
10/02/2012CA2565761C Substituted azaquinazolines having an antiviral action
10/02/2012CA2563017C Substituted cyclohexylacetic acid derivatives
10/02/2012CA2561601C Quaternary ammonium compound, process for producing the same, therapeutic agent for cerebrovascular disorder, and therapeutic agent for heart disease
10/02/2012CA2557752C Hydroxy-6-heteroaryl-phenanthridines and their use as pde4 inhibitors
10/02/2012CA2557115C Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
10/02/2012CA2556390C 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/02/2012CA2553890C Pharmaceutical compositions comprising midazolam in a high concentration
10/02/2012CA2550841C Novel combination of anticholinergic and .beta. mimetics for the treatment of respiratory diseases
10/02/2012CA2549423C Oligonucleotides derived from mycobacterium for stimulating immune function, treating immune-related diseases, atopic dermatitis and/or protecting normal immune cell
10/02/2012CA2546962C Cyclopentyl derivatives
10/02/2012CA2546727C Gtpase inhibitors and methods of use
10/02/2012CA2546300C 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
10/02/2012CA2537114C Tricyclic nucleosides or nucleotides as therapeutic agents
10/02/2012CA2535536C Substituted 3-pyrrolidine-indole derivatives
10/02/2012CA2534022C Di-aryl glycoside derivatives and their use as sglt inhibitors
10/02/2012CA2532594C Antiglucocorticoids for the treatment of catatonia
10/02/2012CA2532415C Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
10/02/2012CA2531486C Saquinavir mesylate oral dosage form
10/02/2012CA2529453C Pyrrolidin-1,2-dicarboxylic acid-1-[(4-ethinyl-phenyl)-amide]-2-[(phenyl)-amide] derivative as inhibitors of coagulation factors xa and viia for the treatment of thromboses
10/02/2012CA2526636C Diaryl ureas for diseases mediated by pdgfr
10/02/2012CA2520172C Novel methods for the treatment of cancer with an indoleamine 2, 3-dioxygenase inhibitor
10/02/2012CA2520115C 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators
10/02/2012CA2517459C Heterobifunctional polymeric bioconjugates
10/02/2012CA2511613C Phosphonooxy quinazoline derivatives and their pharmaceutical use
10/02/2012CA2506956C Synergistic combination comprising roflumilast and (r,r)-formoterol
10/02/2012CA2504207C New amide compounds having mch-antagonistic activity and medicaments comprising these compounds
10/02/2012CA2502848C Use of irl-1620 and paclitaxel for preventing and treating breast tumors
10/02/2012CA2502531C Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
10/02/2012CA2484192C Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
10/02/2012CA2481739C Sustained release of guaifenesin combination drugs
10/02/2012CA2478111C A cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy
10/02/2012CA2470601C Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
10/02/2012CA2466477C A2b adenosine receptor antagonists
10/02/2012CA2465895C Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
10/02/2012CA2438270C Process for the fractionation of cereal brans
10/02/2012CA2417874C Use of ox-2 inhibitors for the treatment of cancer
10/02/2012CA2412795C Improved liposomal camptothecins and uses thereof
10/02/2012CA2402268C Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections
10/02/2012CA2321444C Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects
10/02/2012CA2208841C High molecular weight polymer-based prodrugs
10/02/2012CA2133306C Amplification of human mdm2 gene in human tumors
10/01/2012CA2772416A1 Nicotine-containing patch preparation
09/2012
09/27/2012WO2012129564A2 Proteasome chymotrypsin-like inhibition using pi-1833 analogs
09/27/2012WO2012129562A2 Compounds and methods for inducing chondrogenesis
09/27/2012WO2012129513A2 Blockage of pai-1 in diabetic cd34+ stem cells corrects cellular dysfunction
09/27/2012WO2012129499A1 Treatment of inflammatory and infectious skin disorders
09/27/2012WO2012129495A1 Opioid receptor ligands and methods of using and making same
09/27/2012WO2012129491A1 Trpv3 modulators
09/27/2012WO2012129473A1 Gallium complexes, pharmaceutical compositions and methods of use
09/27/2012WO2012129461A1 Methods for treating or preventing urological inflammation
09/27/2012WO2012129452A2 Propynoic acid carbamoyl methyl-almides and pharmaceutical compositions and methods based thereon
09/27/2012WO2012129394A2 Methods and compositions for the treatment of cancer
09/27/2012WO2012129381A1 Deuterated preladenant
09/27/2012WO2012129365A1 Myelin regeneration with androgens
09/27/2012WO2012129353A1 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds
09/27/2012WO2012129344A1 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
09/27/2012WO2012129338A1 Azole compounds as pim inhibitors
09/27/2012WO2012129324A2 6-substituted estradiol derivatives for use in remyelination of nerve axons
09/27/2012WO2012129305A1 Combination therapy
09/27/2012WO2012129262A1 Treatment of attention deficit/hyperactivity disease
09/27/2012WO2012129258A1 Amidopyrazole inhibitors of interleukin receptor-associated kinases
09/27/2012WO2012129232A1 Compositions for the treatment of psychotic or neurological disorders
09/27/2012WO2012129227A1 Dendritic cells (dcs) targeting for tuberculosis (tb) vaccine
09/27/2012WO2012129222A1 Methods for improving bone health in infants using long chain polyunsaturated fatty acids
09/27/2012WO2012129220A1 Methods for improving bone health in infants using prebiotics
09/27/2012WO2012129156A1 Pharmaceutical compositions comprising sorbitan esters
09/27/2012WO2012129145A1 Nscle combination therapy
09/27/2012WO2012129112A2 Use of intracellular enzymes for the release of covalently linked bioactives
09/27/2012WO2012129084A2 Glucosylceramide synthase inhibitors
09/27/2012WO2012129074A1 Pyrimidine cyclohexyl glucocorticoid receptor modulators
09/27/2012WO2012129073A2 Compositions and methods for tissue engineering and cell based therapies
09/27/2012WO2012129072A1 Solid particulate compositions comprising coenzyme q10
09/27/2012WO2012129066A2 New targets for treatment of er stress
09/27/2012WO2012129057A2 Ssh-2 (slingshot-2) inhibitors and methods for making and using them
1 ... 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 ... 7860